Mutations in influenza virus M1 CCHH, the putative zinc finger motif, cause attenuation in mice and protect mice against lethal influenza virus infection

Journal of Virology

Volumn 80, Issue 12, 2006, Pages 5697-5707

  Hui, Eric Ka Wai ^a   Smee, Donald F ^b   Wong, Min Hui ^b   Nayak, Debi P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UTAH STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHICKEN; CONTROLLED STUDY; EGG; FEMALE; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VIRUS; LETHALITY; LUNG ALVEOLUS CELL; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNINDEXED SEQUENCE; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS MUTANT; VIRUS MUTATION; VIRUS REPLICATION; VIRUS VIRULENCE; WILD TYPE; ZINC FINGER MOTIF;

AMINO ACID MOTIFS; ANIMALS; CELL LINE; CELL PROLIFERATION; HUMANS; INFLUENZA A VIRUS; MICE; MICE, INBRED BALB C; MUTATION; ORTHOMYXOVIRIDAE INFECTIONS; VACCINES, ATTENUATED; VIRAL MATRIX PROTEINS; VIRUS REPLICATION; ZINC FINGERS;

ORTHOMYXOVIRIDAE;

EID: 33744904964     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02729-05     Document Type: Article

References (76)

1. Ali, A., R. T. Avalos, E. Ponimaskin, and D. P. Nayak. 2000. Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein. J. Virol. 74:8709-8719.
2. Baudin, F., I. Petit, W. Weissenhorn, and R. W. H. Ruigrok. 2001. In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein. Virology 281:102-108.
3. Bosch, F. X., W. Garten, H.-D. Klenk, and R. Rott. 1981. Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of avian influenza viruses. Virology 113:725-735.
4. Brown, E., H. Liu, L. Kit, S. Baird, and M. Nesrallah. 2001. Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc. Natl. Acad. Sci. USA 98:6883-6888.
5. Brydon, E. W. A., S. J. Morris, and C. Sweet. 2005. Role of apoptosis and cytokines in influenza virus morbidity. FEMS Microbiol. Rev. 29:837-850.
6. Bui, M., G. Whittaker, and A. Helenius. 1996. Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J. Virol. 70:8391-8401.
7. Castrucci, M. R., and Y. Kawaoka. 1993. Biologic importance of influenza virus stalk length in influenza A virus NA. J. Virol. 67:759-764.
8. Doly, J., A. Civas, S. Navarro, and G. Uze. 1997. Type 1 interferons: expression and signalization. Cell. Mol. Life Sci. 54:1109-1121.
9. Elster, C., E. Fourest, F. Baudin, K. Larsen, S. Cusack, and R. W. H. Ruigrok. 1994. A small percentage of influenza virus M1 protein contains zinc but zinc does not influence in vitro M1-RNA interaction. J. Gen. Virol. 75:37-42.
10. Fislová, T., and F. Kostolanský. 2005. The factors of virulence of influenza A virus. Acta Virol. 49:147-157.
11. Fukuhara, N., C. Huang, K. Klyotani, T. Yoshida, and T. Sakaguchi. 2002. Mutational analysis of the Sendai virus V protein: importance of the conserved residues for Zn binding, virus pathogenesis, and efficient RNA editing. Virology 299:172-181.
12. García-Robles, I., H. Akarsu, C. W. Muller, R. W. H. Ruigrok, and F. Baudin. 2005. Interaction of influenza virus proteins with nucleosomes. Virology 332:329-336.
13. García-Sastre, A. 2001. Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 279:375-384.
14. García-Sastre, A., R. K. Durbin, H. Zheng, P. Palese, R. Gertner, D. E. Levy, and J. E. Durbin. 1998. The role of interferon in influenza virus tissue tropism. J. Virol. 72:8550-8558.
15. Goodbourn, S., L. Didcock, and R. E. Randall. 2000. Interferons: cell signalling, immune modulation, antiviral responses and virus countermeasures. J. Gen. Virol. 81:2341-2364.
16. Govorkova, E. A., A. S. Gambaryan, E. C. Claas, and Y. A. Smirnov. 2000. Amino acid changes in the hemagglutinin and matrix proteins of influenza A (H2) viruses adapted to mice. Acta Virol. 44:241-248.
17. Hatta, M., P. Gao, P. Halfmann, and Y. Kawaoka. 2001. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293:1840-1842.
18. Hatta, M., and Y. Kawaoka. 2002. The continued pandemic threat posed by avian influenza viruses in Hong Kong. Trends Microbiol. 10:340-344.
19. Hennet, T., H. J. Ziltener, J. Frei, and E. Peterhans. 1992. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J. Immunol. 149:932-939.
20. Huang, C., K. Kiyotani, Y. Fujii, N. Fukuhara, A. Kato, Y. Nagai, T. Yoshida, and T. Sakaguchi. 2000. Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesis. J. Virol. 74:7834-7841.
21. Hui, E. K.-W., S. Barman, D. H.-P. Tang, B. France, and D. P. Nayak. 2006. YRKL sequence of influenza virus Ml functions as the L domain motif and interacts with VPS28 and Cdc42. J. Virol. 80:2291-2308.
22. Hui, E. K.-W., S. Barman, T. Y. Yang, and D. P. Nayak. 2003. Basic residues of the helix six domain of influenza virus M1 involved in nuclear translocation of M1 can be replaced by PTAP and YPDL late assembly domain motifs. J. Virol. 77:7078-7092.
23. Hui, E. K.-W., and D. P. Nayak. 2001. Role of ATP in influenza virus budding. Virology 290:329-341.
24. Hui, E. K.-W., and D. P. Nayak. 2002. Role of G protein and protein kinase signalling in influenza virus budding in MDCK cells. J. Gen. Virol. 83:3055-3066.
25. Hui, E. K.-W., K. Ralston, A. K. Judd, and D. P. Nayak. 2003. Conserved cysteine and histidine residues in the putative zinc finger motif of the influenza A virus M1 protein are not critical for influenza virus replication. J. Gen. Virol. 84:3105-3113.
26. Hui, E. K.-W., E. M. Yap, D. S. An, I. S. Y. Chen, and D. P. Nayak. 2004. Inhibition of influenza virus matrix (M1) protein expression and virus replication by U6 promoter-driven and lentivirus-mediated delivery of siRNA. J. Gen. Virol. 85:1877-1884.
27. 2 zinc finger proteins. Cell. Mol. Life Sci. 58:625-635.
28. Judd, A. K., A. Sanchez, D. J. Bucher, J. H. Huffman, K. Bailey, and R. W. Sidwell. 1997. In vivo anti-influenza virus activity of a zinc finger peptide. Antimicrob. Agents Chemother. 41:687-692.
29. Julkunen, I., K. Melén, M. Nyqvist, J. Pirhonen, T. Sareneva, and S. Matikainen. 2001. Inflammatory responses in influenza A virus infection. Vaccine 19:S32-S37.
30. Kawaoka, Y., A. Nestorowicz, D. J. Alexander, and R. G. Webster. 1987. Molecular analyses of the hemagglutinin genes of H5 influenza viruses: origin of a virulent turkey strain. Virology 158:218-227.
31. Klenk, H.-D., and W. Garten. 1994. Activation cleavage of viral spike proteins by host proteases, p. 241-280. In E. Wimmer (ed.), Cellular receptors for animal viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
32. Kobasa, D., A. Takada, K. Shinya, M. Hatta, P. Halfmann, S. Theriault, H. Suzuki, H. Nishimura, K. Mitamura, N. Sugaya, T. Usui, T. Murata, Y. Maeda, S. Watanabe, M. Suresh, T. Suzuki, Y. Suzuki, H. Feldmann, and Y. Kawaoka. 2004. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431:703-707.
33. Kurokawa, M., M. Imakita, C. A. Kumeda, and K. Shiraki. 1996. Cascade of fever production in mice infected with influenza virus. J. Med. Virol. 50:152-158.
34. Lamb, R. A., and R. M. Krug. 2001. Orthomyxoviridae: the viruses and their replication, p. 725-769. In D. M. Knipe and P. M. Howley (ed.), Fundamental virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
35. Liu, T., and Z. Ye. 2005. Attenuating mutations of the matrix gene of influenza A/WSN/33 virus. J. Virol. 79:1918-1923.
36. Liu, T., and Z. Ye. 2002. Restriction of viral replication by mutation of the influenza virus matrix protein. J. Virol. 76:13055-13061.
37. Lu, X., T. M. Tumpey, T. Morken, S. R. Zaki, N. J. Cox, and J. M. Katz. 1999. A mouse model for the evaluation of pathogenesis and immunity to influenza A (HSN1) viruses isolated from human. J. Virol. 73:5903-5911.
38. McCullers, J. A., E. Hoffmann, V. C. Huber, and A. D. Nickerson. 2005. A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulence. Virology 336: 318-326.
39. Miller, J. L., and E. M. Anders. 2003. Virus-cell interactions in the induction of type 1 interferon by influenza virus in mouse spleen cells. J. Gen. Virol. 84:193-202.
40. Nakajima, S., and A. Sugiura. 1980. Neurovirulence of influenza virus in mice. II. Mechanism of virulence as studied in a neuroblastoma cell line. Virology 101:450-457.
41. Nasser, E. H., A. K. Judd, A. Sanchez, D. Anastasiou, and D. J. Bucher. 1996. Antiviral activity of influenza virus M1 zinc finger peptides. J. Virol. 70:8639-8644.
42. Nayak, D. P., and E. K.-W. Hui. 2002. Assembly and morphogenesis of influenza viruses. Recent Res. Dev. Virol. 4:35-54.
43. Nayak, D. P., E. K.-W. Hui, and S. Barman. 2004. Assembly and budding of influenza virus. Virus Res. 106:147-165.
44. Novak, M., Z. Moldoveanu, D. P. Schafer, J. Mestecky, and R. W. Compans. 1993. Murine model for evaluation of protective immunity to influenza virus. Vaccine 11:55-60.
45. Okada, A., T. Miura, and H. Takeuchi. 2003. Zinc- and pH-dependent conformational transition in a putative interdomain linker region of the influenza virus matrix protein M1. Biochemistry 42:1978-1984.
46. Patterson, S., J. Gross, and J. S. Oxford. 1988. The intracellular distribution of influenza virus matrix protein and nucleoprotein in infected cells and their relationship to hemagglutinin in the plasma membrane. J. Gen. Virol. 69: 1859-1872.
47. Peper, R. L., and H. Van Campen. 1995. Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb. Pathog. 19:175-183.
48. Pleschka, S., T. Wolff, C. Ehrhardt, G. Hobom, O. Planz, U. R. Rapp, and S. Ludwig. 2001. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat. Cell Biol. 3:301-305.
49. Reinhardt, J., and T. Wolff. 2000. The influenza A virus M1 protein interacts with the cellular receptor of activated C kinase (RACK) 1 and can be phosphorylated by protein kinase C. Vet. Microbiol. 74:87-100.
50. Ress, P. J., and N. J. Dimmock. 1981. Electrophoretic separation of influenza virus ribonucleoproteins. J. Gen. Virol. 53:125-132.
51. Ress, P. J., and N. J. Dimmock. 1982. Kinetics of synthesis of influenza virus ribonucleoprotein structures. J. Gen. Virol. 59:403-408.
52. Ronni, T., T. Sareneva, J. Pirhonen, and I. Julkunen. 1995. Activation of IFN-α, IFN-γ, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J. Immunol. 154: 2764-2774.
53. Ruigrok, R. W. H., and F. Baudin. 1995. Structure of influenza virus ribonucleoprotein particles. II. Purified RNA-free influenza virus ribonucleoprotein from structures that are indistinguishable from the intact influenza virus ribonucleoprotein particles. J. Gen. Virol. 76:1009-1114.
54. Sareneva, T., S. Matikainen, M. Kurimoto, and I. Julkunen. 1998. Influenza A virus-induced IFN-α/β and IL-18 synergistically enhance IFN-γ gene expression in human T cells. J. Immunol. 160:6032-6038.
55. Schlesinger, R. W., P. J. Husak, G. L. Bradshaw, and P. P. Panayotov. 1998. Mechanisms involved in natural and experimental neuropathogenicity of influenza viruses: evidence and speculation. Adv. Virus Res. 50:289-379.
56. Schmitt, A. P., and R. A. Lamb. 2005. Influenza virus assembly and budding at the viral budzone. Adv. Virus Res. 64:383-416.
57. Schulman, J. L. 1968. The use of an animal model to study transmission of influenza virus infection. Am. J. Public Health Nations Health 58:2092-2096.
58. Sidwell, R. W., and D. F. Smee. 2001. In vitro and in vivo assay systems for study of influenza virus inhibitors. Antivir. Res. 48:1-16.
59. Sidwell, R. W., D. F. Smee, J. H. Huffman, D. L. Barnard, K. W. Bailey, J. D. Morrey, K. Bush, and Y. S. Babu. 2001. The in vivo influenza-inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201. Antimicrob. Agents Chemother. 45:749-757.
60. Smeenk, C. A., and E. G. Brown. 1994. The influenza virus variant A/FM/1/ 47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth. J. Virol. 68:530-534.
61. Smeenk, C. A., K. E. Wright, B. F. Burns, A. J. Thaker, and E. G. Brown. 1996. Mutations in the hemagglutinin and matrix genes of a virulent influenza virus variant, A/FM/1/47-MA, control different stages in pathogenesis. Virus Res. 44:79-95.
62. Steinhauer, D. A. 1999. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258:1-20.
63. Steinhauer, D. A., and J. J. Skehel. 2002. Genetics of influenza viruses. Annu. Rev. Genet. 36:305-332.
64. Subbarao, E. K., M. Perkins, J. J. Treanor, and B. R. Murphy. 1992. The attenuation phenotype conferred by the M gene of the influenza A/Ann Arbor/6/60 cold-adapted virus (H2N2) on the A/Korea/82 (H3N2) reassortant virus results from a gene constellation effect. Virus Res. 25:37-50.
65. Sugiura, A., and M. Ueda. 1980. Neurovirulence of influenza virus in mice. I. Neurovirulence of recombinants between virulent and avirulent virus strains. Virology. 101:440-449.
66. Tashiro, M., and R. Rott. 1996. The role of proteolytic cleavage of viral glycoproteins in the pathogenesis of influenza virus infections. Semin. Virol. 7:237-243.
67. Tumpey, T. M., C. F. Basler, P. V. Aguilar, H. Zeng, A. Solórzano, D. E. Swayne, N. J. Cox, J. M. Katz, J. K. Taubenberger, P. Palese, and A. García-Sastre. 2005. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310:77-80.
68. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
69. Vacheron, F., A. Rudent, S. Perin, C. Labarre, A. M. Quero, and M. Guenounou. 1990. Production of interleukin 1 and tumor necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virus. J. Gen. Virol. 71:477-479.
70. Van Reeth, K. 2000. Cytokines in the pathogenesis of influenza. Vet. Microbid. 74:109-116.
71. Wakefield, L., and G. G. Brownlee. 1989. RNA-binding properties of influenza A virus matrix protein M1. Nucleic Acids Res. 17:8569-8580.
72. Ward, A. 1997. Virulence of influenza A virus for mouse lung. Virus Genes 14:187-194.
73. Welsh, R. M., and G. C. Sen. 1997. Nonspecific host responses to viral infections, p. 109-141. In N. Nathanson (ed.), Viral pathogenesis. Lippincott-Raven Publishers, Philadelphia, Pa.
74. Yasuda, J., D. J. Bucher, and A. Ishihama. 1994. Growth control of influenza A virus by M1 protein: analysis of transfectant viruses carrying the chimeric M gene. J. Virol. 68:8141-8146.
75. Ye, Z., T. Liu, D. P. Offringa, J. McInnis, and R. A. Levandowski. 1999. Association of influenza virus matrix protein with ribonucleoproteins. J. Virol. 73:7467-7473.
76. Zhimov, O. P., and H.-D. Klenk. 1997. Histones as a target for influenza virus matrix protein M1. Virology 235:302-310.